Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.603ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.603ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.603ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.603NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.70ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.70NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.606ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.606ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.606ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.606NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.601ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.601ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.601ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.601NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.186ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.186ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.186ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.186NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.324ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.324ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.324ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.324NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.525ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.525ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.525NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.480ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.480ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.480ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.480NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.214ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.214ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.304ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.304ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.304NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.214.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.214.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.577ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.577ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.577ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.577NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.639ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used